股票简称:模塑科技 编号:2014-008 股票代码:000700 江南模塑科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |-------------------------|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | √特定对象调研 | □ ...

证券代码:000700 编号:【2015-001】 证券简称:模塑科技 江南模塑科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |-----------------------------|---------------------------------------------------------|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | | √特定对象调研 | □分析师会议 | | | | □媒体采访 | □业 ...

Group 1: Business Development and Market Expansion - Moulding Technology is a leader in the domestic automotive bumper sector, focusing on high-end clients such as BMW and Mercedes-Benz, while also planning to develop new brands to drive growth [2]. - The company is actively expanding into overseas markets, having secured some orders from the German BMW Group and planning to invest in a factory in Mexico, expected to commence production in 2018 [2]. - Efforts will be made to enhance lean production management, optimize production lines, improve logistics and warehousing, and strengthen employee skills to increase product quality and competitiveness [2]. Group 2: Healthcare Sector Investment - Mingci Hospital is being built as a large specialized hospital focusing on cardiovascular diseases and diabetes, with additional services in health management and elderly care [3]. - The hospital is expected to open in early 2016, supported by the Heart and Diabetes Center of North Rhine-Westphalia and several renowned domestic hospitals [3]. - The hospital is projected to operate at a loss for the first three years, with an expected net profit of approximately 30 million yuan in the fourth year, increasing annually thereafter [3].

Group 1: Business Overview - The main customers of Mould Technology are concentrated in the domestic high-end market, including brands like BMW, Mercedes-Benz, General Motors, and Volkswagen [1] - The supply volume of Mould Technology accounts for 85% of BMW's domestic models and 100% of Mercedes-Benz's domestic models [1] Group 2: Overseas Market Expansion - Mould Technology has established a wholly-owned subsidiary, MingHua de Mexico, in San Luis Potosi, Mexico, with plans to complete the factory by 2018 [2] - A project team has been formed to oversee the construction of the Mexican factory, and recruitment and training efforts are underway [2] Group 3: Healthcare Sector Development - The company aims to develop Mingci Hospital into a large specialized hospital focusing on cardiovascular diseases and diabetes, with a strong emphasis on high-end health check-ups and management [2] - Mingci Hospital currently employs over 270 medical staff and continues to recruit additional personnel [2] - The hospital is expected to officially open in early 2016, following extensive modifications to the original building layout [2] Group 4: Future Business Strategy - Mould Technology plans to position the healthcare sector as its second main business, aiming to become a new profit growth point [2] - The company will seek quality projects for acquisition and expansion after accumulating sufficient specialized experience from Mingci Hospital [2]

Group 1: Business Growth and Strategy - Mould Technology's main business focuses on two areas: traditional automotive parts and medical services, with a stable growth trajectory since 2011 [2] - The automotive industry is currently at a bottleneck, but the company is positioned to keep pace with the development of complete vehicles, primarily serving the domestic mid-to-high-end market [2] - The company has seen significant performance increases, particularly with new brand developments from BMW and Mercedes, while domestic brands contribute a smaller portion to overall sales [3] Group 2: Raw Material Impact - The company’s raw materials, primarily plastic granules derived from petroleum, experience some price fluctuations, but the impact is limited [3] - The company maintains a strict supply chain with global suppliers, ensuring that they meet the requirements of major manufacturers [3] Group 3: Future Growth from Medical Services - Mingci Hospital is positioned as a future profit growth point, currently in the final stages of decoration and expected to commence operations in October [3] - The hospital will focus on cardiovascular diseases and will also offer diabetes management and health services, with a staffing plan of 160 medical personnel [3] - Mingci Hospital is eligible to enter the medical insurance system, enhancing its potential for patient acquisition and revenue generation [3]

Group 1: Company Overview and Market Position - The company has established subsidiaries in Shanghai, Beijing, Shenyang, Wuhan, and Yantai, providing bumper assembly services to high-end car manufacturers such as BMW, Mercedes-Benz, General Motors, and Volkswagen, with BMW's market share in domestic models at 80-90% and Mercedes-Benz at 100%, contributing 70% to the company's profits [3] - The company is actively expanding its customer base, targeting new clients like Land Rover and Volvo to increase market share and revenue [3] Group 2: International Expansion - The company plans to invest $150 million to establish subsidiaries in the United States and Mexico to support BMW's local factories and aftermarket development, reflecting its product quality and management system at an international level [3] - This move marks the company's entry into the North American market, aiming to leverage German technology and resources [3] Group 3: Future Technology and Innovation - The company is focusing on smart driving technologies, including millimeter-wave radar and laser radar, and is preparing for potential mergers or collaborations in this field [3] - The decision to develop smart driving initiatives outside the listed company is to mitigate early-stage investment risks, with plans to integrate successful projects into the listed company once they reach a certain scale [3] Group 4: Healthcare Business Development - The healthcare division has successfully completed over 30 surgeries, previously requiring patients to travel to major cities for treatment, now being managed at Mingci Hospital [3] - Future plans include utilizing the Mingze Hospital management platform to invest in or acquire medical institutions and elderly care facilities to enhance the hospital's development [3]

股票代码:000700 江南模塑科技股份有限公司投资者关系活动记录表 股票简称:模塑科技 编号:【2016-002】 | --- | --- | --- | |--------------------|---------------------------------|---------------------------------------------------------------------------------------------------------------------| | | | | | | √特定对象调研 | □分析师会议 | | 投资者关系活动类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | 口其他 (请文字说明其他活动内容) | | | | 浦银安盛:刘诗瑶 | 签名:享】 | | | 华富基金:傅晟 | 签名: | | | 兴业全球:张弘 | 签名: | | | 浙商证券:李丰 | 签名: | | | 浙商证券:曹梦悦 | 签名: | | | | | | | 上海信托:陆方 | 签名: | | 参 ...

Group 1: Client Expansion and Market Position - The company primarily focuses on high-end domestic clients, including BMW, Mercedes-Benz, General Motors, and Volkswagen, and is actively seeking to expand its client base to include brands like Land Rover and Volvo to increase market share and revenue [1] - BMW's domestic models account for 85% of the supply volume from Mould Technology, highlighting the company's significant role as a supplier [1] - A new factory is planned near BMW's facility in Mexico, with production expected to start in 2017, aimed at supporting BMW's operations [1] Group 2: Hospital Project and Profit Expectations - The Mingci Hospital is currently in a mature trial operation phase, with an opening ceremony scheduled for January 22, 2016, and the company is optimistic about its future prospects [1] - The hospital project is anticipated to contribute positively to the company's profits [2] Group 3: Business Performance and Future Directions - The company's main business profit from key clients like BMW and Mercedes-Benz is projected to account for over 30% of total annual revenue [2] - The company is considering entering the smart driving sector within its bumper business, reflecting a commitment to innovation and adaptation to technological advancements [2]

Group 1: Overseas Expansion - In July 2015, the company established a subsidiary in Mexico to support BMW's local manufacturing, with a planned production capacity of 400,000 sets [2] - In January 2016, the company set up a subsidiary in the United States, also to support BMW, and is currently advancing the construction and personnel training for both overseas projects [2] Group 2: Hospital Operations - Since its official operation in February 2016, the hospital has treated approximately 2,200 patients in the first half of the year, performing several interventional and cardiac surgeries [3] - The hospital has all necessary equipment in place and does not require significant fixed asset investments in the future, with plans to utilize surrounding idle properties for related business extensions [3] Group 3: Automotive Parts Supply - The company's joint venture brand clients are primarily in the domestic mid-to-high-end market, with a significant focus on high-end vehicles, particularly BMW and Mercedes-Benz [3] - The company is working to secure more orders for new models as domestic manufacturers increasingly localize imported models, and has begun small-scale supply for Jaguar Land Rover and Volvo's domestic models [3]

Group 1: Market Position and Competition - The company holds a 100% supply share for domestic Mercedes-Benz models, although the sales volume is not included in the consolidated revenue due to ownership structure [2] - The company has signed a strategic contract for the next ten years with BMW, holding a 75% supply share [2] - The company is actively seeking cooperation opportunities with various automakers, including Land Rover and Volvo, amidst competition with Yanfeng and FAW Fuwei [2] Group 2: Project Developments - The South Carolina project is scheduled to commence production in October 2017, aiming to reach breakeven within three years [2] - The Mexico project, which has a larger investment, is progressing more slowly, with an expected output of over 300,000 sets and a necessary profitability ramp-up period [2] - Orders for the Mexico and China projects are bundled together, with contracts extending to 2025 [2] Group 3: Healthcare Operations - As of the third quarter, the hospital has treated approximately 2,800 patients and performed nearly 70 cardiac surgeries [2] - The hospital's surgical volume has significantly increased since being included in local health insurance, with around 90 cardiac surgeries performed [2] - The hospital is leveraging strategic partnerships for technical support to enhance its brand and operational efficiency [2]